13 completed, 11 unknown, 2 recruiting, 1 enrolling by invitation. 8 Not applicable, 5 Phase 2, 4 Phase 1, 3 Phase 4, 1 Early Phase 1.
Follow Hepatic Carcinoma: new trials by email Literature Review of Hepatic Carcinoma trials Research Report on Hepatic Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Laryngopharyngeal Injury After Endotracheal Intubation Under General Anesthesia Gastric Cancer, Hepatic Carcinoma | Recruiting | Zhejiang University | 1200 | 2025-11-01 | 2026-01-22 | |
| An Exosome-Based Liquid Biopsy for the Differential Diagnosis of Primary Liver Cancer ELUCIDATE - Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma | Recruiting | City of Hope Medical Center | 400 | 2024-03-15 | 2026-07-07 | |
| A Study of Ga-68 Dolacga to Evaluate Liver Reserve Function in Patients With HCC Before and After Proton Therapy Ga-68 Dolacga Injection - Hepatic Carcinoma | Not applicable | Unknown | National Atomic Research Institute, Taiwan | 10 | 2023-12-20 | 2023-12-27 |
| Efficacy and Safety of Octreotide in Laparoscopic Hepatectomy Surgery: Effect on Blood Loss, Need for Vasoactive Drugs, Transfusion Requirements. Octreotide, Placebo - Hepatic Carcinoma, Hepatic Metastasis | Phase 2 | Unknown | Clinica Universidad de Navarra, Universidad de Navarra | 62 | 2023-08-14 | 2023-10-17 |
| Liver Resection for Patients With Hepatocellular Carcinoma and Clinically Significant Portal Hypertension transarterial chemoembolisation - Hepatic Carcinoma | Completed | Tang-Du Hospital | 3000 | 2023-01-01 | 2024-02-07 | |
| A Study to Evaluate Vaccines Against COVID-19 in the Real World Chronic Liver Disease, Hepatic Carcinoma | Withdrawn | Humanity & Health Medical Group Limited | 2022-08-01 | 2022-08-03 | ||
| to Assess the Accuracy and Reliability of the Ga68-Dolacga Positron Emission Tomography Compared to Computer Tomography Volumetry and Indocyanine Green Retention Test for Measurement of Liver Reserve Ga68-Dolacga Injection - Hepatic Carcinoma | Phase 2 | Completed | National Atomic Research Institute, Taiwan | 30 | 2021-12-14 | 2023-12-13 |
| ESP Block on Patient Outcomes in Patients With Liver Tumor Undergoing Radiofrequency Ablation Group ESP, Non-blocked Group - Hepatic Carcinoma | Not applicable | Unknown | TC Erciyes University | 30 | 2021-05-15 | 2021-08-17 |
| Prehabilitation and Posttransplant Training Program in Liver Transplantation Prehabilitation, Prehabilitation and posttransplant training program - Liver Transplant; Complications, Cirrhosis, Liver | Not applicable | Enrolling by invitation | Maria dels Angels Cebria i Iranzo, PT, PhD | 60 | 2021-04-01 | 2025-09-15 |
| Development of a Neuronal Microscope genetic model - Hepatic Carcinoma | Not applicable | Completed | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | 30 | 2021-01-01 | 2026-03-27 |
| Radiotherapy With Iron Oxide Nanoparticles (SPION) on MR-Linac for Primary & Metastatic Hepatic Cancers Ferumoxytol injection - Liver Neoplasms, Hepatic Cirrhosis | Unknown | Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) | 40 | 2020-11-19 | 2024-01-31 | |
| A Clinical Study in Patients With High-risk Recurrent Primary Hepatocellular Carcinoma Using Autologous TILs Tumor infiltrating lymphocyte - Hepatic Carcinoma | Phase 1 / Phase 2 | Unknown | CAR-T (Shanghai) Cell Biotechnology Co., Ltd. | 40 | 2020-08-26 | 2020-09-04 |
| Combined Locoregional Treatment With Immunotherapy for Unresectable HCC. Sintilimab, Microwave Ablation, TACE - Hepatic Carcinoma | Phase 1 | Unknown | Shanghai Zhongshan Hospital | 45 | 2020-01-01 | 2024-08-01 |
| Arterial Base Fluorescence Segmental Positive Staining Superselective Intra-arterial Hepatic Injection of Indocyanine Green (ICG) for Fluorescence Image-guided Segmental Positive Staining - Hepatic Carcinoma | Not applicable | Completed | Chang Gung Memorial Hospital | 8 | 2018-07-09 | 2020-02-12 |
| Transarterial Chemoembolization in Combination With Nivolumab Performed for Intermediate Stage Hepatocellular Carcinoma Nivolumab, TACE - Carcinoma, Hepatocellular, Hepatic Carcinoma | Phase 2 | Completed | AIO-Studien-gGmbH | 49 | 2018-06-14 | 2023-07-20 |
| The Investigation of Peginterferon Alfa-2a on the RFS of the Subjects With HCC Who Have Been Treated by Resection ETV；TDF；ADV, Peginterferon Alfa-2a - Chronic Hepatitis b, Hepatic Carcinoma | Phase 4 | Unknown | Huashan Hospital | 432 | 2017-09-01 | 2017-09-08 |
| Endoscopic Ultrasound Guided Liver Biopsy 22 gauge needle liver biopsy - Hepatic Cancer, Hepatic Neoplasm | Not applicable | Completed | AdventHealth | 40 | 2017-08-01 | 2019-02-11 |
| Exhaustive Genetic and Immunological Characterization of Colon, Kidney and Liver Tumors Colorectal Adenocarcinoma, Hepatic Carcinoma | Unknown | European Georges Pompidou Hospital | 150 | 2017-05-01 | 2017-05-17 | |
| Impact of Three-dimensional Visualization on Operation Strategy and Complications for Complex Hepatic Carcinoma Hepatic Carcinoma | Unknown | Zhujiang Hospital | 2000 | 2017-03-15 | 2018-04-19 | |
| Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil/Leucovorin Versus Sorafenib in Advanced Hepatocellular Carcinoma FOLFOX regimen, Sorafenib 200Mg Tab - Liver Cancer, Hepatic Carcinoma | Phase 3 | Completed | Sun Yat-sen University | 262 | 2017-03-01 | 2020-12-16 |
Showing 20 of 29. Sign in to see all of them.
Carcinoma, Hepatocellular (29) · Liver Neoplasms (7) · Carcinoma, Renal Cell (2) · Cholangiocarcinoma (2) · Colonic Neoplasms (2) · Liver Cirrhosis (2) · Lung Neoplasms (2) · Pancreatic Neoplasms (2) · Stomach Neoplasms (2) · Carcinoma, Squamous Cell (1) · Esophageal Neoplasms (1) · Fibrosis (1) · Head and Neck Neoplasms (1) · Hepatitis B, Chronic (1) · Hoarseness (1)
Adenocarcinoma (29) · Carcinoma (29) · Digestive System Diseases (29) · Digestive System Neoplasms (29) · Liver Diseases (29) · Neoplasms (29) · Neoplasms by Histologic Type (29) · Neoplasms by Site (29) · Neoplasms, Glandular and Epithelial (29) · Liver Neoplasms (22) · Pathological Conditions, Signs and Symptoms (7) · Pathologic Processes (5) · Gastrointestinal Diseases (3) · Gastrointestinal Neoplasms (3) · Male Urogenital Diseases (3)
3-(4-(2-fluoroethoxy)phenyl)-2-(3-methyl-2-(4-((2-sulfamoylbenzo(d)thiazol-6-yloxy)methyl)-1H-1,2,3-triazol-1-yl)butanamido)propanoic acid (1) · Breathing Exercises (1) · Ferrosoferric Oxide (1) · Folfox protocol (1) · H3B-6527 (1) · Immunotherapy, Adoptive (1) · Injections (1) · Models, Genetic (1) · Nivolumab (1) · Octreotide (1) · Preoperative Exercise (1) · Sorafenib (1) · huaier (1) · peginterferon alfa-2a (1) · sintilimab (1)
Fuda Cancer Hospital, Guangzhou (2) · National Atomic Research Institute, Taiwan (2) · Qidong Gaitianli Medicines Co., Ltd (2) · AIO-Studien-gGmbH (1) · AdventHealth (1) · Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) (1) · CAR-T (Shanghai) Cell Biotechnology Co., Ltd. (1) · Chang Gung Memorial Hospital (1) · City of Hope Medical Center (1) · Clinica Universidad de Navarra, Universidad de Navarra (1) · European Georges Pompidou Hospital (1) · First Affiliated Hospital of Chengdu Medical College (1) · Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico (1) · H3 Biomedicine Inc. (1) · Huashan Hospital (1)
China (13) · United States (6) · Taiwan (4) · Spain (3) · France (2) · Italy (2) · Belgium (1) · Canada (1) · Germany (1) · Hong Kong (1) · Japan (1) · Russia (1) · Singapore (1) · South Korea (1) · Turkey (Türkiye) (1)
Xiaoping Chen, Professor (2) · Ajay Goel, PhD (1) · Alexander Kirichenko, MD, PhD (1) · Arndt Vogel, Prof.Dr. (1) · Bing-Shen Huang, MD (1) · David Calatayud Mizrahi, MD, PhD (1) · Diansan Su (1) · George Lau, MD (1) · Jimimg Zhang (1) · Laura Arjona Tinaut, PT (1) · Luis Compte Torrero, MD, PhD (1) · Lunxiu Qin (1)
PMID 18543027, PMID 19301311, PMID 22508790, PMID 22968066, PMID 23282740, PMID 23579506, PMID 23818301, PMID 24696183, PMID 25135446, PMID 25347551, PMID 26266387, PMID 26321447, PMID 29802174, PMID 2996162, PMID 32557715, PMID 33787401, PMID 34905388, PMID 40436447
2016 (1), 2017 (1)